Oct 8, 2024, 08:36 AM by

Oct 8, 2024, 08:18 AM by

Coronado Research announced the engagement of Rob Nichols to support the build-out of its clinical technology practice and advise the executive leadership team as they deliver the broader company vision.

Oct 8, 2024, 01:00 AM by User Not Found

Bio-IT World | In a data science paper published in June, a team of researchers at MIT presents GenSQL, a system to ease answering data science questions. They published the work in Proceedings of the ACM on Programming Languages. GenSQL is available open source in Clojure on GitHub.

Oct 3, 2024, 07:45 AM by

The combined organization offers life sciences companies predictive biosimulation and scientific informatics capabilities, improving certainty in decision-making from discovery through commercialization.

Oct 3, 2024, 07:38 AM by

Oct 3, 2024, 07:38 AM by

Proscia®, a global leader in AI-enabled pathology solutions for precision medicine, today announced the launch of Concentriq® Embeddings and the Proscia AI Toolkit, enabling life sciences organizations to accelerate the discovery and development of novel therapies and diagnostics.

Oct 3, 2024, 01:00 AM by User Not Found

Bio-IT World | New work from Dr. Lachlan Jolly and the University of Adelaide’s Neurobiology Research Group is using cutting-edge RNA-based techniques to resolve genetic variants of uncertain significance (VUS) that can't be diagnosed through traditional methods. Many disease-causing genes do not express RNA in accessible tissues like blood or skin, leaving many patients without a clear diagnosis. To overcome this, the team is utilizing two innovative methods—transactivation and transdifferentiation.

Oct 2, 2024, 06:47 AM by

The accelerator seeks next-generation digital health solutions supporting preparedness and response to health security threats

Oct 2, 2024, 06:47 AM by

Oct 2, 2024, 06:47 AM by

The National Institute of Diabetes and Digestive and Kidney Diseases Awards Vaxess SBIR Phase I Funding to Test Company’s MIMIX Transdermal Patch Platform in Administering GLP-1 RA Therapies

Oct 2, 2024, 06:47 AM by

Sphere Fluidics has introduced Cyto-Mine Chroma – the second generation of its award-winning, flagship Cyto-Mine single cell analysis and isolation platform. With the upgrade to a four-color laser and detector system, Chroma offers enhanced capabilities to further maximise the efficiency and precision of single-cell functional analysis workflows. By accelerating the early selection of superior candidate cells, it supports project timelines to be reduced from months to weeks, and minimising effort and cost.

Oct 2, 2024, 06:47 AM by

This press release announces the partnership between Zymo Research and BluMaiden Biosciences to provide end-to-end clinical trial analytics and reporting services based on the human microbiome. We believe this development will be of significant interest to your audience, particularly those working in the pharmaceutical sector. The press release highlights how the new joint service will cover every stage of human microbiome analysis, including fit-for-purpose sample collection, nucleic acid purification, next-generation sequencing, sophisticated bioinformatics data analysis, and detailed clinical trial reporting. This service is designed to be applicable across entire trial cohorts and can be applied to a broad range of disease indications and intervention modalities, making it especially valuable for researchers and professionals in the pharma industry with the aim of enhancing therapeutic efficacy and commercial lifespan.

Oct 2, 2024, 01:00 AM by User Not Found

Bio-IT World | The longstanding reality for most individuals infected with human immunodeficiency virus (HIV) is a lifetime of taking antiretroviral therapy (ART). But the creation of an HIV-like virus particle that both reduces viral reservoirs and boosts the immune system could make it possible for at least half of all patients to achieve long-term control of the virus after a brief stint of treatment.

Oct 1, 2024, 07:32 AM by

VieCure Inc. announced the completion of a $45 million financing led by Northpond Ventures and the appointment of industry veteran Richard Daly as chairman of the board of directors.

Oct 1, 2024, 07:32 AM by

Oct 1, 2024, 01:00 AM by User Not Found

Bio-IT World | In a paper published last month in Brain, researchers explored data from 24 past Alzheimer’s Disease trials and posited a new theory for why the most recent drugs have shown some success against the disease, and senior author Alberto Espay issued an open data challenge for pharma companies working in the space.

Sep 30, 2024, 06:10 AM by

CluePoints furthers its commitment to delivering innovative solutions that enhance clinical trial efficiency with this latest addition to its enterprise software platform

Sep 27, 2024, 07:47 AM by

ResultsCX, a provider of Customer Experience Management (CXM) services to leading global companies including Fortune 100 and 500 firms, today announced it was honored as a Major Contender in Everest Group’s Customer Experience Management (CXM) Services PEAK Matrix® Assessment (Americas region) for the fourth consecutive year. This recognition underlines the company’s ongoing expansion and commitment to supporting organizations across industries in optimizing consumer experience (CX) and driving growth.

Sep 26, 2024, 08:16 AM by

Sep 26, 2024, 08:16 AM by

Takara Bio Europe has announced the launch of the Shasta™ Single-Cell System, a high-throughput NGS solution enabling novel biomarker discovery in oncology research, at the 2024 Human Cell Atlas General Meeting. This comprehensive system combines well-validated chemistries with user-friendly bioinformatics tools, allowing researchers to mine more genomic and transcriptomic information from a much greater number of cells than previously possible, all while reducing both time and costs. The Shasta system and Shasta Whole-Genome Amplification (WGA) Kit increases throughput by processing up to 1,500 cells per run, compared to current technologies which are limited to 384 single cells, while also enabling the detection of single-cell level CNV events via shallow sequencing. Its ability to detect RNA biotypes, such as non-polyadenylated lncRNAs, otherwise missed by current droplet-based technologies represents a significant advancement over traditional plate-based full-length RNA-seq and high-throughput mRNA-seq methods.